EP1539985A4 - Therapeutische polypeptide, diese codierende nukleinsäuren sowie verwendungsverfahren - Google Patents

Therapeutische polypeptide, diese codierende nukleinsäuren sowie verwendungsverfahren

Info

Publication number
EP1539985A4
EP1539985A4 EP02793885A EP02793885A EP1539985A4 EP 1539985 A4 EP1539985 A4 EP 1539985A4 EP 02793885 A EP02793885 A EP 02793885A EP 02793885 A EP02793885 A EP 02793885A EP 1539985 A4 EP1539985 A4 EP 1539985A4
Authority
EP
European Patent Office
Prior art keywords
methods
nucleic acids
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02793885A
Other languages
English (en)
French (fr)
Other versions
EP1539985A2 (de
Inventor
John P Ii Alsobrook
Enrique Alvarez
David W Anderson
Melanie Baron
Ferenc L Boldog
Catherine E Burgess
Stacie J Casman
Andrei Chapoval
Mohanraj Dhanabal
Shlomit R Edinger
Andrew Eisen
Karen Ellerman
Seth Ettenberg
Esha A Gangolli
Valerie L Gerlach
Linda Gorman
William M Grosse
Xiaojia Guo
Craig Hackett
Weizhen Ji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority claimed from US10/287,971 external-priority patent/US20040067882A1/en
Publication of EP1539985A2 publication Critical patent/EP1539985A2/de
Publication of EP1539985A4 publication Critical patent/EP1539985A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP02793885A 2001-11-05 2002-11-05 Therapeutische polypeptide, diese codierende nukleinsäuren sowie verwendungsverfahren Withdrawn EP1539985A4 (de)

Applications Claiming Priority (39)

Application Number Priority Date Filing Date Title
US33862601P 2001-11-05 2001-11-05
US338626P 2001-11-05
US33660001P 2001-12-05 2001-12-05
US336600P 2001-12-05
US33828501P 2001-12-07 2001-12-07
US338285P 2001-12-07
US34134601P 2001-12-12 2001-12-12
US341346P 2001-12-12
US34154001P 2001-12-17 2001-12-17
US34147701P 2001-12-17 2001-12-17
US341540P 2001-12-17
US341477P 2001-12-17
US34259201P 2001-12-20 2001-12-20
US342592P 2001-12-20
US34429701P 2001-12-27 2001-12-27
US344297P 2001-12-27
US34490301P 2001-12-31 2001-12-31
US344903P 2001-12-31
US37328802P 2002-04-17 2002-04-17
US373288P 2002-04-17
US38098102P 2002-05-15 2002-05-15
US380981P 2002-05-15
US38149502P 2002-05-17 2002-05-17
US381495P 2002-05-17
US38353402P 2002-05-28 2002-05-28
US38374402P 2002-05-28 2002-05-28
US383534P 2002-05-28
US383744P 2002-05-28
US38402402P 2002-05-29 2002-05-29
US38382902P 2002-05-29 2002-05-29
US383829P 2002-05-29
US384024P 2002-05-29
US40178802P 2002-08-07 2002-08-07
US401788P 2002-08-07
US40635302P 2002-08-26 2002-08-26
US406353P 2002-08-26
PCT/US2002/035536 WO2003040330A2 (en) 2001-11-05 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US10/287,971 US20040067882A1 (en) 2001-10-22 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US287971 2002-11-05

Publications (2)

Publication Number Publication Date
EP1539985A2 EP1539985A2 (de) 2005-06-15
EP1539985A4 true EP1539985A4 (de) 2006-06-28

Family

ID=32512865

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02793885A Withdrawn EP1539985A4 (de) 2001-11-05 2002-11-05 Therapeutische polypeptide, diese codierende nukleinsäuren sowie verwendungsverfahren

Country Status (3)

Country Link
EP (1) EP1539985A4 (de)
CA (1) CA2460653A1 (de)
WO (1) WO2003040330A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050053988A1 (en) * 2003-08-08 2005-03-10 The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Gene expressed in breast cancer and methods of use
WO2005072340A2 (en) 2004-01-27 2005-08-11 Compugen Ltd. Novel polynucleotides encoding polypeptides and methods using same
EP1771474B1 (de) 2004-07-20 2010-01-27 Genentech, Inc. Angiopoietin-like 4 protein hemmer kombinationen und deren verwendung
CA2574791A1 (en) 2004-07-20 2006-02-09 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
WO2006043271A1 (en) * 2004-10-22 2006-04-27 Compugen Ltd. Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
US10842849B2 (en) * 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
CN119306833B (zh) * 2023-07-11 2025-09-16 东莞市朋志生物科技有限公司 抗降钙素原抗体、检测降钙素原的试剂和试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033996A2 (en) * 1996-03-11 1997-09-18 Bayer Corporation Human bikunin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033996A2 (en) * 1996-03-11 1997-09-18 Bayer Corporation Human bikunin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KAWAGUCHI T ET AL: "Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 272, no. 44, 31 October 1997 (1997-10-31), pages 27558 - 27564, XP002311334, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
CA2460653A1 (en) 2003-05-15
WO2003040330A2 (en) 2003-05-15
EP1539985A2 (de) 2005-06-15
WO2003040330A8 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
WO2003023008A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1576169A4 (de) Therapeutische polypeptide, diese codierende nukleinsäuren und verwendungsverfahren
EP1487864A4 (de) Therapeutische polypeptide, diese codierende nukleinsäuren und verwendungsverfahren
AU2002356534A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU9633301A (en) Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
EP1446419A4 (de) Therapeutische polypeptide, für diese codierende nukleinsäuren und anwendungsverfahren
EP1432726A4 (de) Therapeutische polypeptide, nukleinsäuren, die für diese kodieren, und anwendungsverfahren
EP1401858A4 (de) Therapeutische polypeptide, nukleinsäuren, die für diese codieren, und verfahren zur anwendung
WO2003040330A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1532238A4 (de) Therapeutische polypeptide, diese codierende nukleinsäuren und verwendungsverfahren
EP1443913A4 (de) Therapeutische polypeptide, diese codierende nukleinsäuren sowie verwendungsverfahren
EP1549671A4 (de) Therapeutische polypeptide, diese kodierende nukleinsaüre und verwendungsverfahren
EP1399537A4 (de) Therapeutische polypeptide, diese codierende nukleinsäuren und verwendungsverfahren
EP1383533A4 (de) Proteine und diese kodierende nukleinsäuren
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002365216A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003270424A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003304034A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU4157002A (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002303232A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003060149A9 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1504026A4 (de) Therapeutische polypeptide, diese codierende nukleinsäuren und verwendungsverfahren
AU2002360485A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040521

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CURAGEN CORPORATION

A4 Supplementary search report drawn up and despatched

Effective date: 20060530

17Q First examination report despatched

Effective date: 20070206

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070817